Get started
Author

Elham Hosseini

ORCID: 0000-0002-6866-6699
Observed ORCID: 0000-0002-6866-6699
OpenAlex ID: A5021638140
Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma
2015 · Fatemeh Shidfar, Seyed H. Ghaffari, et al. · Anti-Cancer Agents in Medicinal Chemistry · 9
Effect of a Nurse-Led Cognitive-Behavioral Therapy on Sleep Quality in Patients Undergoing Open Heart Surgery: A Prospective Randomized Clinical Trial
2024 · Seyede Fatemeh Gheiasi, Elham Hosseini, et al. · Health Scope · 7
PDF
Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature
2023 · Elham Hosseini, Foroud Shahbazi · Current Drug Safety · 5
Survivin isoform expression in arsenic trioxide‐treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin‐2α
2016 · Majid Zaki Dizaji, Seyed H Ghaffari, et al. · Asia-Pacific Journal of Clinical Oncology · 5
Differential sensitivity of p44/p42-MAPK- and PI3K/Akt-targeted neuroblastoma subtypes to arsenic trioxide
2013 · Meysam Yousefi, Seyed H. Ghaffari, et al. · Neurochemistry International · 5
Assessment of drug-drug interactions among patients with hematologic malignancy: A clinical pharmacist-led study
2024 · Sogol Zarrabi, Elham Hosseini, et al. · Journal of Oncology Pharmacy Practice · 4
Works count: 6
Citation count: 35
H-index: 5
I10-index:
Year
Topic
Type